Discover Opportunities months before the RFP drops
Learn more →Retrieving contract details... Hang tight!
See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis
This contract includes 1 purchase order from Aug 6, 2025 to Aug 6, 2025
| Buyer | Vendor | Issued Date | Quantity |
|---|---|---|---|
| National Institutes of Health NIDA | Agilent Technologies Inc | Aug 6, 2025 | 1 |
Full Purchase Intelligence Available
Get complete pricing, descriptions, and financial details for all 1 purchase orders
Unlock Full Details →See what competitors charge and their contract structure
Spot renewal opportunities 6-12 months before expiration
Analyze buyer's purchasing history and vendor preferences
Track expiration dates across all your target accounts
Reach decision-makers before renewal with competitive intel
Our customers win 3x more contract renewals and replacements
No public files available for this contract.
Contract documentation may be available through official government sources or agency portals. Starbridge can help you track down and retrieve these files.
PROMPT POINT-OF-CARE HIV VIRAL LOAD MONITORING
Effective Date
Sep 1, 2025
Expires
Effective: Sep 1, 2025
PROMPT POINT-OF-CARE HIV VIRAL LOAD MONITORING
ActiveDEVELOPMENT OF A RAPID, QUANTITATIVE HIV-1 ASSAY FOR VIRAL LOAD SELF-MONITORING
Effective Date
Sep 1, 2025
Expires
Effective: Sep 1, 2025
DEVELOPMENT OF A RAPID, QUANTITATIVE HIV-1 ASSAY FOR VIRAL LOAD SELF-MONITORING
ActiveTO DISCOVER AND CHARACTERIZE B CELL EPITOPES AGAINST THE VIRAL PATHOGENS RVFV, CCHFV, AND EV-D68.
Effective Date
Sep 16, 2024
Expires
Effective: Sep 16, 2024
TO DISCOVER AND CHARACTERIZE B CELL EPITOPES AGAINST THE VIRAL PATHOGENS RVFV, CCHFV, AND EV-D68.
ActiveCOVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
Effective Date
Sep 1, 2020
Expires
Effective: Sep 1, 2020
COVID-19. TO DEVELOP SMALL SYNTHETIC CHEMICAL MOLECULES AS BROADLY ACTIVE ANTIVIRAL FOR THE TREATMENT OF VIRAL INFECTIONS.
ActiveSee who's winning contracts, track spending trends, and identify your best opportunities before your competition.
Schedule Your Demo →Premium
Clean & enrich your CRM automatically
Premium
Get complete source documentation & analysis